Volume | 0 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | Mínimo Máximo |
||||||
Minimo del Dia |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Quince Therapeutics Inc | QNCX | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.96 |
Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
---|---|---|---|
0 | 0 | - | 0.84 - 1.74 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
- | 0 | US$ 0.96 | USD |
Información Financiera Quince Therapeutics Inc QNCX
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
41.15M | 42.87M | - | 0 | -31.39M | -0.73 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Quince Therapeutics Inc QNCX
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
01/4/2024 | 06:00 | Business Wire | Quince Therapeutics Provides Business Update and Reports.. |
22/2/2024 | 06:00 | Business Wire | Quince Therapeutics Launches Scientific Advisory Board |
15/2/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
15/2/2024 | 06:00 | Business Wire | Quince Therapeutics Appoints Former Reata Pharmaceuticals.. |
07/2/2024 | 15:05 | Business Wire | Quince Therapeutics to Present at Oppenheimer 34th Annual.. |
02/2/2024 | 16:53 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
05/1/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
04/1/2024 | 15:05 | Business Wire | Quince Therapeutics to Participate at Investor Events in.. |
03/1/2024 | 15:02 | Edgar (US Regulatory) | Form 8-K - Current report |
22/12/2023 | 15:08 | Edgar (US Regulatory) | Form 8-K - Current report |
14/12/2023 | 17:21 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
08/12/2023 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos QNCX
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.01 | 1.12 | 0.93 | 1.03 | 79,439 | -0.05 | -4.95% |
1 Month | 1.03 | 1.12 | 0.89 | 1.01 | 102,806 | -0.07 | -6.80% |
3 Months | 1.32 | 1.42 | 0.89 | 1.12 | 71,725 | -0.36 | -27.27% |
6 Months | 0.9395 | 1.4301 | 0.84 | 1.11 | 82,036 | 0.0205 | 2.18% |
1 Year | 1.57 | 1.74 | 0.84 | 1.23 | 138,294 | -0.61 | -38.85% |
3 Years | 39.98 | 121.98 | 0.5401 | 10.91 | 615,083 | -39.02 | -97.60% |
5 Years | 20.00 | 121.98 | 0.5401 | 15.27 | 432,742 | -19.04 | -95.20% |